Crizanlizumab
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 145 publications
Optimizing the right time to start sickle cell therapies.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.
Journal: Journal of comparative effectiveness research
Published: November 24, 2025
The Role of Pediatric Clinicians in the Diagnosis, Management, and Referral of Priapism in Children and Adolescents with Sickle Cell Disease.
Journal: Pediatric clinics of North America
Published: November 09, 2025
Low Use of FDA-Approved Medications for Sickle Cell Disease in Adults.
Journal: European journal of haematology
Published: October 23, 2025
Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy.
Journal: Cureus
Published: October 21, 2025
Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 15, 2025
Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global Context.
Journal: Biomedicines
Published: July 06, 2025
Now where do we STAND with crizanlizumab?
Journal: The Lancet. Haematology
Published: February 03, 2025
Low bone mineral density and pain impact in adults with sickle cell disease.
Journal: Blood advances
Published: January 21, 2025
Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
Journal: British journal of haematology
Published: January 20, 2025
Last Updated: 02/24/2026